UMD subawards CAR/NRF2 chemo metabolism study to MSU
Trusted by teams at
Description
The University of Maryland awarded a $72,233 subaward to Michigan State University to assess the impact of CAR and NRF2 dual activation on cyclophosphamide bioactivation and doxorubicin detoxification. Trustees approved acceptance in April 2026.
Contract Details
Contract Amount
$72,233
Vendor
UNIVERSITY OF MARYLAND
Agency
Michigan State University, MI
Contract Type
OTHER
Document Date
April 10, 2026
More from UNIVERSITY OF MARYLAND
More from Michigan State University
Michigan State University Board of Trustees Entertain You Productions Service Agreement April 2026
Michigan State University Board of Trustees Gift, Grant and Contract Report April 2026
Michigan State University Board of Trustees Gift, Grant and Contract Report April 2026
Michigan State University Board of Trustees Gift, Grant and Contract Report April 2026
Michigan State University Board of Trustees Gift, Grant and Contract Report April 2026
Get alerts on contract renewals, new awards, and vendor activity.
See live SLED buying signals, source docs, decision-makers, contract context, and the next step into your CRM or pipeline.